or
forgot password
  • cancer clinical trials in buffalo, NY

  • Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Myelodysplastic Syndrome
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Endometrial Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Breast Cancer
    Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Roswell Park Cancer Institute

    Trial Locations
    Roswell Park Cancer Institute
    Veterans Affairs Medical Center - Buffalo
    Metastatic Cancer, Prostate Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Kidney Cancer
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Prostate Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Brain and Central Nervous System Tumors
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers.
    Roswell Park Cancer Institute Rosewell SC
    Buffalo, New York 14263
    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome, Systemic Mastocytosis
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma and Plasma Cell Neoplasm
    Temozolomide and Radiation Therapy in Treating Patients With Gliomas
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Brain and Central Nervous System Tumors
    Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
    Roswell Park Cancer Center
    Buffalo, New York 14263
    Chronic Lymphoproliferative Diseases
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA Western New York Healthcare System at Buffalo
    Buffalo, New York 14215
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Urologic Neoplasms
    Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Unspecified Adult Solid Tumor, Protocol Specific
    Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Cervical Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Roswell Park Cancer Institute

    Trial Locations
    Roswell Park Cancer Institute
    Veterans Affairs Western New York Health Care System-Buffalo
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Fallopian Tube Cancer, Ovarian Cancer
    Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lymphoma
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Veterans Affairs Medical Center - Buffalo
    Buffalo, New York 14215
    Colorectal Cancer
    Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Acute Lymphocytic Leukemia
    Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Esophageal Cancer, Precancerous Condition
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    Roswell Park Cancer Institute

    Trial Locations
    Roswell Park Cancer Institute
    Buffalo General Hospital
    Melanoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
    Roswell Park Cancer Institute

    Trial Locations
    Roswell Park Cancer Institute
    Veterans Affairs Medical Center - Buffalo
    Esophageal Cancer
    Fludarabine-based Conditioning for Severe Aplastic Anemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Anemia, Aplastic
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Roswell Park Cancer Institute

    Trial Locations
    Roswell Park Cancer Institute
    Veterans Affairs Western New York Health Care System-Buffalo
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer